DC-201
PTC-M, Dr.Cure’s proprietary therapeutic adjuvant can be applied to another environment that overexpresses ROS, especially inflammatory diseases.
Manganese oxide in PTC-M has already proven its anti-inflammatory efficacy by administering it to a renal inflammation (Journal of Nanobiotechnology; 2022; 20:205) and gout model (in preparation) with ROS scavenging ability.
Manganese oxide in PTC-M has already proven its anti-inflammatory efficacy by administering it to a renal inflammation (Journal of Nanobiotechnology; 2022; 20:205) and gout model (in preparation) with ROS scavenging ability.
Development of Therapeutics
for Renal Inflammatory Diseases
for Renal Inflammatory Diseases
Micelle complex loaded with Mn₃O₄ nanoparticles based on
PTC drug delivery system was developed for anti-inflammatory effect and inhibition of macrophage infliltration.
Journal of Nanobiotechnology; 2022; 10-1186/s12951-022-01410-z,
PTC drug delivery system was developed for anti-inflammatory effect and inhibition of macrophage infliltration.
Journal of Nanobiotechnology; 2022; 10-1186/s12951-022-01410-z,
Domestic patent registration completed: 10-2021-0128246,
International patent PCT application completed: PCT/KR2022/009070
